US-based biopharmaceutical services company Quintiles has a new chief executive officer (CEO), Tom Pike, who has spent much of his career to date at management consulting, technology services and outsourcing specialists Accenture.
In what Quintiles described as part of the company’s long-term succession planning, Pike will take over from Dennis Gillings, who founded Quintiles in 1982 and was until now its chairman and CEO. Gillings will continue at Quintiles as executive chairman of the company’s board of directors.
Pike will take up his position on 30 April 2012. He brings to Quintiles 30 years’ experience in a variety of sectors, including 22 years at Accenture. Among his leadership roles at the management consultants, Pike headed up the North America Health and Products business segments.
Before that, he was global chief operating officer for Accenture’s Resources operating group. Pike also served as the company’s chief strategy officer. Since leaving Accenture in 2010, he has been involved in a number of start-ups in the technology and healthcare sectors.
“Tom has an impressive track record of helping customers navigate fast-changing environments and solving complex business issues,” Gillings commented. “He has experience with organisations our size and much larger that will be extremely valuable to us.”
Gillings also referred to Pike’s “disciplined and forthright approach”, which would “enable him to earn the trust of customers and employees alike”.P